23E2 Stock Overview
Designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Ekso Bionics Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.65 |
| 52 Week High | US$2.80 |
| 52 Week Low | US$0.63 |
| Beta | 1.48 |
| 11 Month Change | -29.72% |
| 3 Month Change | -20.00% |
| 1 Year Change | -57.87% |
| 33 Year Change | -78.17% |
| 5 Year Change | -90.96% |
| Change since IPO | -98.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| 23E2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.1% | -1.0% | -0.02% |
| 1Y | -57.9% | -7.3% | 8.2% |
Return vs Industry: 23E2 underperformed the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: 23E2 underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| 23E2 volatility | |
|---|---|
| 23E2 Average Weekly Movement | 10.0% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 23E2's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 23E2's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 71 | Scott Davis | www.eksobionics.com |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Ekso Bionics Holdings, Inc. Fundamentals Summary
| 23E2 fundamental statistics | |
|---|---|
| Market cap | €15.21m |
| Earnings (TTM) | -€10.69m |
| Revenue (TTM) | €16.98m |
0.9x
P/S Ratio-1.4x
P/E RatioIs 23E2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 23E2 income statement (TTM) | |
|---|---|
| Revenue | US$17.68m |
| Cost of Revenue | US$8.52m |
| Gross Profit | US$9.17m |
| Other Expenses | US$20.30m |
| Earnings | -US$11.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.51 |
| Gross Margin | 51.84% |
| Net Profit Margin | -62.95% |
| Debt/Equity Ratio | 36.0% |
How did 23E2 perform over the long term?
See historical performance and comparison